Your browser doesn't support javascript.
loading
The Role of Multiparametric MRI and MRI-targeted Biopsy in the Diagnosis of Radiorecurrent Prostate Cancer: An Analysis from the FORECAST Trial.
Light, Alexander; Kanthabalan, Abi; Otieno, Marjorie; Pavlou, Menelaos; Omar, Rumana; Adeleke, Sola; Giganti, Francesco; Brew-Graves, Chris; Williams, Norman R; Emara, Amr; Haroon, Athar; Latifoltojar, Arash; Sidhu, Harbir; Freeman, Alex; Orczyk, Clement; Nikapota, Ashok; Dudderidge, Tim; Hindley, Richard G; Virdi, Jaspal; Arya, Manit; Payne, Heather; Mitra, Anita V; Bomanji, Jamshed; Winkler, Mathias; Horan, Gail; Moore, Caroline M; Emberton, Mark; Punwani, Shonit; Ahmed, Hashim U; Shah, Taimur T.
Afiliação
  • Light A; Imperial Prostate, Department of Surgery and Cancer, Imperial College London, London, UK; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Kanthabalan A; Division of Surgery & Interventional Science, University College London, London, UK.
  • Otieno M; Division of Surgery & Interventional Science, University College London, London, UK.
  • Pavlou M; Department of Statistical Science, University College London, London, UK.
  • Omar R; Department of Statistical Science, University College London, London, UK.
  • Adeleke S; Department of Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK; School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.
  • Giganti F; Division of Surgery & Interventional Science, University College London, London, UK; Department of Radiology, University College London Hospital NHS Foundation Trust, London, UK.
  • Brew-Graves C; Division of Medicine, Faculty of Medicine, University College London, London, UK.
  • Williams NR; Division of Surgery & Interventional Science, University College London, London, UK.
  • Emara A; Department of Urology, Basingstoke and North Hampshire Hospital, Hampshire Hospitals NHS Foundation Trust, Basingstoke, UK.
  • Haroon A; Department of Nuclear Medicine, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK; Institute of Nuclear Medicine, University College London Hospitals NHS Foundation Trust, London, UK.
  • Latifoltojar A; Division of Medicine, Faculty of Medicine, University College London, London, UK; Department of Radiology, Royal Marsden NHS Foundation Trust, Surrey, UK.
  • Sidhu H; Department of Radiology, University College London Hospital NHS Foundation Trust, London, UK; Division of Medicine, Faculty of Medicine, University College London, London, UK.
  • Freeman A; Department of Histopathology, University College London Hospital NHS Foundation Trust, London, UK.
  • Orczyk C; Division of Surgery & Interventional Science, University College London, London, UK; Department of Urology, University College London Hospital NHS Foundation Trust, London, UK.
  • Nikapota A; Sussex Cancer Centre, Royal Sussex County Hospital, University Hospitals Sussex NHS Foundation Trust, Brighton, UK.
  • Dudderidge T; Department of Urology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Hindley RG; Department of Urology, Basingstoke and North Hampshire Hospital, Hampshire Hospitals NHS Foundation Trust, Basingstoke, UK.
  • Virdi J; Department of Urology, The Princess Alexandra Hospital NHS Trust, Harlow, UK.
  • Arya M; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Payne H; Department of Histopathology, University College London Hospital NHS Foundation Trust, London, UK.
  • Mitra AV; Department of Oncology, University College London Hospital NHS Foundation Trust, London, UK.
  • Bomanji J; Institute of Nuclear Medicine, University College London Hospitals NHS Foundation Trust, London, UK.
  • Winkler M; Imperial Prostate, Department of Surgery and Cancer, Imperial College London, London, UK; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Horan G; Department of Oncology, Queen Elizabeth Hospital, The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust, King's Lynn, UK.
  • Moore CM; Division of Surgery & Interventional Science, University College London, London, UK; Department of Urology, University College London Hospital NHS Foundation Trust, London, UK.
  • Emberton M; Division of Surgery & Interventional Science, University College London, London, UK; Department of Urology, University College London Hospital NHS Foundation Trust, London, UK.
  • Punwani S; Department of Radiology, University College London Hospital NHS Foundation Trust, London, UK; Division of Medicine, Faculty of Medicine, University College London, London, UK.
  • Ahmed HU; Imperial Prostate, Department of Surgery and Cancer, Imperial College London, London, UK; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK; Division of Surgery & Interventional Science, University College London, London, UK.
  • Shah TT; Imperial Prostate, Department of Surgery and Cancer, Imperial College London, London, UK; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK; Division of Surgery & Interventional Science, University College London, London, UK. Electronic address: t.shah@i
Eur Urol ; 85(1): 35-46, 2024 01.
Article em En | MEDLINE | ID: mdl-37778954
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Imageamento por Ressonância Magnética Multiparamétrica Tipo de estudo: Diagnostic_studies Limite: Humans / Male Idioma: En Revista: Eur Urol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Imageamento por Ressonância Magnética Multiparamétrica Tipo de estudo: Diagnostic_studies Limite: Humans / Male Idioma: En Revista: Eur Urol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido